 |
 |

Disproportionate Septal Hypertrophy Associated With Erythroblastosis Fetalis
MAJ Brian S. Carter, MC, USA;
Jane E. DiGiacomo, MD;
LCDR Scott M. Balderston, MC, USN;
James W. Wiggins, MD;
Gerald B. Merenstein, MD
Am J Dis Child. 1990;144(11):1225-1228.
Abstract
 |  |
We retrospectively reviewed clinical and echocardiographic data on 10 new-borns with erythroblastosis fetalis who were admitted to our nurseries between 1984 and 1988 and who required a doublevolume exchange transfusion and neonatal intensive care. Echocardiograms were performed in the first 48 hours of life. In 5 patients, disproportionate septal hypertrophy was demonstrated; 1 additional patient had biventricular hypertrophy with a thickened septum but not disproportionate septal hypertrophy. The mean septal: left ventricular free-wall ratio for the group (n=10) was 1.37. No correlation was apparent between the occurrence of disproportionate septal hypertrophy and new-born glucose, bilirubin, or hematocrit values. When analyzed separately, the 4 patients who did not receive intrauterine blood transfusions had a ratio of 1.73 ± 0.21 (mean ± SEM); this was significantly greater than the ratio in the 6 patients who were transfused in utero (1.13±0.24). In patients who underwent transfusions, there was no correlation between the number of transfusions and the septal:left ventricular ratio. This study reports a significant but previously unrecognized cardiac hypertrophy with disproportionate septal hypertrophy in patients with erythroblastosis fetalis. Our data suggest a sparing effect of intrauterine fetal transfusions. The mechanism by which these transfusions may affect the hypertrophic development of the myocardium remains to be determined.
(AJDC. 1990;144:1225-1228)
Author Affiliations
From the Lubchenco Center for Perinatal Research (Drs Carter and Merenstein) and Department of Pediatrics (Drs DiGiacomo, Balderston, and Wiggins), University of Colorado School of Medicine, Denver.
Footnotes
Accepted for publication March 26, 1990.
The views of the authors do not purport to reflect the positions of the Departments of the US Army, US Navy, or Defense.
Reprint requests to Division of Perinatal Medicine, Box B-199, University of Colorado Health Sciences Center, 4200 E Ninth Ave, Denver, CO 80262 (Dr Carter).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cardiac effects of short course dexamethasone in preterm infants
Skelton et al.
Arch. Dis. Child. Fetal Neonatal Ed. 1998;78:133F-137.
ABSTRACT
| FULL TEXT
|